EC Gynaecology

Case Report Volume 13 Issue 8 - 2024

Cervical Adenosarcoma: 12 Years of Follow Up After Conservative Therapy

>Andreia Relva1*, Margarida Bernardino2 and Ana Francisca Jorge3

1Gynecology Consultant, Gynecology Department, Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal

1Chief Department, Gynecology Department, Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal

2Head Department, Gynecology Department, Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal

*Corresponding Author: Andreia Relva, Gynecology Consultant, Gynecology Department, Instituto Português de Oncologia Francisco Gentil, Lisboa, Portugal.
Received: July 16, 2024; Published: July 25, 2024



Cervical adenosarcoma is a rare gynaecological malignancy defined as a biphasic tumor with a benign epithelial component and a malignant stromal component. Cervical localization is more common in younger patients, who frequently desire fertility preservation. Conservative strategy, in the absence of heterologous elements or lymphovascular space invasion, is becoming a preferred approach. Only a few cases have been reported, with no recurrence. Therefore, long-term follow up is essential.

We present a 15-year-old patient, with a polypoid mass of the cervix. She was submitted to excision of the polypoid lesion followed by conization.

There was no recurrence in the 12 years period of follow up.

Keywords: Adenosarcoma; Cervix; Fertility Preservation; Surveillance

  1. Nathenson MJ., et al. “Uterine adenosarcoma: a review”. Current Oncology Reports 11 (2016): 68.
  2. Clement PB and Scully RE. “Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature”. Human Pathology 4 (1990): 363-381.
  3. Patrelli TS., et al. “Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature”. BMC Cancer 11 (2011): 236.
  4. Verschraegen CF., et al. “Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience”. Oncology Reports 4 (1998): 939-944.
  5. Santiago NL., et al. “Management and survival of patients with Mullerian adenosarcoma of the cervix without sarcomatous overgrowth desiring fertility preservation, a case report and review of the literature”. Gynecologic Oncology Reports 32 (2019): 100525.
  6. Fleming NA., et al. “Mullerian adenocarcinoma of the cervix in a 10-year-old girl: case report and review of the literature”. Journal of Pediatric and Adolescent Gynecology 4 (2009): e45-51.
  7. Yuan Z., et al. “Uterine and cervical adenosarcoma: A retrospective study of overall oncologic outcomes and fertility preservation in early-stage disease”. Oncologist 9 (2019): 870-e879.
  8. Li JY., et al. “Clinicopathological characteristics and oncologic outcomes in adenocarcinoma of gynecologic sites”. Gynecologic Oncology Reports11 (2021): 100913.
  9. Lin-Satoi E., et al. “Uterine cervical adenocarcinoma showing an endophytic growth pattern”. Journal of Medical Cases 8 (2022): 402-407.
  10. Kanayama S., et al. “Case report of successful childbearing after conservative surgery for cervical mullerian adenosarcoma”. Case Reports in Obstetrics and Gynecology (2017): 4187416.
  11. L´Heveder A Jones BP., et al. “Conservative management of uterine adenosarcoma: lessons learned from 20 years of follow up”. Archives of Gynecology and Obstetrics5 (2019): 1383-1389.

Andreia Relva., et al. "Cervical Adenosarcoma: 12 Years of Follow Up After Conservative Therapy". EC Gynaecology 13.8 (2024): 01-03.